Operating Income
Operating Income
Biogen Operating Income increased by 4.0% to $610.70M in Q1 2022 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Detailed definition
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
Peer comparison
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
Metric ID:
operating_incomeHistorical Data
4 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | |
|---|---|---|---|---|
| Value | $485.70M | $794.00M | $587.10M | $610.70M |
| QoQ Change | — | +63.5% | -26.1% | +4.0% |
Range$485.70M – $794.00M
Operating Income at Other Companies
Frequently Asked Questions
- What is Biogen's operating income?
- Biogen (BIIB) reported operating income of $610.70M in Q1 2022.
- What does operating income mean?
- The profit a company makes from its core business operations before interest and taxes.